4 completed. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
Follow Burn: new trials by email Literature Review of Burn trials Research Report on Burn
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vitamin E Supplementation in Burned Patients Vitamin E - Burn | Phase 2 / Phase 3 | Completed | The University of Texas Medical Branch, Galveston | 27 | 2013-02-01 | 2026-07-20 |
| Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites estradiol (Zesteem) - Burn, Trauma | Phase 3 | Completed | Renovo | 148 | 2007-01-01 | 2009-08-28 |
| Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care DGD - Burn | Phase 3 | Completed | MediWound Ltd | 182 | 2005-12-01 | 2011-05-10 |
| Virtual Reality Pain Control During Burn Wound Care Virtual Reality Distraction - Burn | Phase 2 / Phase 3 | Completed | National Institute of General Medical Sciences (NIGMS) | 184 | 2002-02-01 | 2013-04-19 |
Burns (4) · Inflammation (1) · Varicose Ulcer (1) · Wounds and Injuries (1)
Wounds and Injuries (3) · Cardiovascular Diseases (1) · Leg Ulcer (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases (1) · Skin Ulcer (1) · Skin and Connective Tissue Diseases (1) · Varicose Veins (1) · Vascular Diseases (1)
Estradiol (1) · Vitamin E (1) · alpha-Tocopherol (1) · alpha-tocopheryl nicotinate (1)
MediWound Ltd (1) · National Institute of General Medical Sciences (NIGMS) (1) · Renovo (1) · The University of Texas Medical Branch, Galveston (1)
Germany (2) · United Kingdom (2) · United States (2) · Australia (1) · Brazil (1) · France (1) · Israel (1) · Italy (1) · Latvia (1) · Poland (1) · Romania (1) · Russia (1) · Slovakia (1)
David R. Patterson, Ph.D. (1) · Ken Dunn, MD (1) · Linda E Sousse, PhD, MBA (1) · Lior Rosenberg, MD (1) · Perenlei Enkhbaatar, MD, PhD (1)
R01GM042725 (1)